Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 140, Issue 3, Pages 495-503
Publisher
Wiley
Online
2016-08-24
DOI
10.1002/ijc.30399
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer
- (2016) Kazushi Inoue et al. INTERNATIONAL JOURNAL OF CANCER
- Human DMTF1β antagonizes DMTF1α regulation of the p14ARF tumor suppressor and promotes cellular proliferation
- (2015) Mario P. Tschan et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Potential of overcoming resistance to HER2-targeted therapies through the PI3K/Akt/mTOR pathway
- (2015) Sharon T. Wilks BREAST
- Non-HER2 signaling pathways activated in resistance to anti-HER2 therapy in breast cancer
- (2015) Adela Madrid-Paredes et al. BREAST CANCER RESEARCH AND TREATMENT
- 4-IHC classification of breast cancer subtypes in a large cohort of a clinical cancer registry: use in clinical routine for therapeutic decisions and its effect on survival
- (2015) Elisabeth Christine Inwald et al. BREAST CANCER RESEARCH AND TREATMENT
- Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
- (2015) Giovanni Ciriello et al. CELL
- Triple negative breast cancer chemosensitivity and chemoresistance: current advances in biomarkers indentification
- (2015) Fouzia Guestini et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Transcription factors that interact with p53 and Mdm2
- (2015) Kazushi Inoue et al. INTERNATIONAL JOURNAL OF CANCER
- Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy
- (2015) Daniel L. Abravanel et al. JOURNAL OF CLINICAL INVESTIGATION
- DMP1β, a splice isoform of the tumour suppressorDMP1locus, induces proliferation and progression of breast cancer
- (2015) Dejan Maglic et al. JOURNAL OF PATHOLOGY
- Triple negative breast cancer: looking for the missing link between biology and treatments
- (2015) Giuseppe Palma et al. Oncotarget
- Regulation of ERBB3/HER3 signaling in cancer
- (2015) Kalpana Mujoo et al. Oncotarget
- ARF tumor suppression in the nucleolus
- (2014) Leonard B. Maggi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Activated d16HER2 Homodimers and SRC Kinase Mediate Optimal Efficacy for Trastuzumab
- (2014) L. Castagnoli et al. CANCER RESEARCH
- Targeting the NFκB Signaling Pathways for Breast Cancer Prevention and Therapy
- (2014) Wei Wang et al. CURRENT MEDICINAL CHEMISTRY
- Cooperation between Dmp1 Loss and Cyclin D1 Overexpression in Breast Cancer
- (2013) Sinan Zhu et al. AMERICAN JOURNAL OF PATHOLOGY
- The ErbB/HER family of protein-tyrosine kinases and cancer
- (2013) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Dmp1α Inhibits HER2/neu-Induced Mammary Tumorigenesis
- (2013) Elizabeth A. Fry et al. PLoS One
- Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts
- (2013) Adam D Pfefferle et al. GENOME BIOLOGY
- Dmp1 Physically Interacts with p53 and Positively Regulates p53's Stability, Nuclear Localization, and Function
- (2012) D. P. Frazier et al. CANCER RESEARCH
- Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models
- (2012) P. J. Roberts et al. CLINICAL CANCER RESEARCH
- NF- B, the first quarter-century: remarkable progress and outstanding questions
- (2012) M. S. Hayden et al. GENES & DEVELOPMENT
- Biomarkers for the clinical management of breast cancer: International perspective
- (2012) Neill Patani et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer
- (2012) D Maglic et al. ONCOGENE
- Hunk is required for HER2/neu-induced mammary tumorigenesis
- (2011) Elizabeth S. Yeh et al. JOURNAL OF CLINICAL INVESTIGATION
- Nuclear Cyclin D1/CDK4 Kinase Regulates CUL4 Expression and Triggers Neoplastic Growth via Activation of the PRMT5 Methyltransferase
- (2010) Priya Aggarwal et al. CANCER CELL
- Critical Roles of DMP1 in Human Epidermal Growth Factor Receptor 2/neu-Arf-p53 Signaling and Breast Cancer Development
- (2010) P. Taneja et al. CANCER RESEARCH
- The ARF tumor suppressor: Structure, functions and status in cancer
- (2010) Peggy Ozenne et al. INTERNATIONAL JOURNAL OF CANCER
- MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer
- (2009) Pankaj Taneja et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Mouse xenograft models vs GEM models for human cancer therapeutics
- (2008) A. Richmond et al. Disease Models & Mechanisms
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started